Related Experiment Video
Updated: May 1, 2026
09:47
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
4.3K
Stem cells, retinal ganglion cells and glaucoma
Valentin M Sluch1, Donald J Zack
1Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Md., USA.
Developments in Ophthalmology
|April 16, 2014
Summary
Stem cell differentiation holds promise for treating optic nerve diseases like glaucoma by replacing damaged retinal ganglion cells (RGCs) or secreting protective factors. This research explores stem cell potential for vision restoration and drug screening.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Ophthalmology
Background:
- Retinal ganglion cells (RGCs) are crucial for vision, transmitting visual information from the retina to the brain.
- Damage to RGCs, as seen in glaucoma, results in irreversible vision loss due to limited nerve regeneration in mammals.
- Stem cell technology offers potential therapeutic strategies for optic nerve diseases.
Purpose of the Study:
- To review the current state of stem cell research for treating glaucoma and other optic nerve diseases.
- To highlight the potential of stem cell differentiation into RGCs for therapeutic applications.
- To explore the use of stem cell-derived cells in drug screening for optic nerve conditions.
Main Methods:
- Review of existing literature on stem cell differentiation and its application in ophthalmology.
- Focus on stem cell differentiation protocols specifically for generating RGCs.
- Discussion of therapeutic potentials including cell replacement and neuroprotection.
Main Results:
- Stem cell differentiation can yield RGCs for potential cell replacement therapy.
- Stem cell-derived cells can secrete factors that promote RGC survival and survival.
- Stem cell applications extend to drug screening for novel optic nerve disease treatments.
Conclusions:
- Stem cell differentiation is a promising avenue for developing new treatments for RGC diseases like glaucoma.
- Further research into stem cell therapies could lead to vision restoration and improved management of optic nerve damage.
- Stem cells offer a versatile platform for both regenerative medicine and pharmaceutical research in ophthalmology.
Related Concept Videos
00:50Unrenewable Cells
2.1K
In humans, the photoreceptor cells of the eye and sensory hair cells of the ear lack stem cells. These cells are thus unrenewable and cannot be replaced when they are damaged or destroyed.
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
2.1K
01:32The Retina
56.6K
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
56.6K
01:20Anatomy of the Eyeball
8.6K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
8.6K